VIDEO: Abrocitinib safe and efficacious in AD patients with or without allergic comorbiditiesJeremy VisserDec 13, 20231 min readAccording to a recent study, abrocitinib is efficacious and well tolerated in atopic dermatitis (AD) patients with or without allergic comorbidities.https://youtu.be/hTaIVaIT8cg
Comments